早产诊断检测套组市场规模、份额及成长分析（按测试类型、检体类型、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，早产诊断检测套组市场规模将达到 1.6377 亿美元，到 2025 年将达到 1.7621 亿美元，到 2033 年将达到 3.1662 亿美元，预测期（2026-2033 年）的复合年增长率为 7.6%。

早产诊断检测套组市场正经历显着成长，这主要得益于早产发生率的上升以及对早期检测方法的迫切需求。这些试剂盒利用生物标记分析和临床指标进行高效的风险评估，而医护人员和孕妇对早产的意识提升，也推动了这一增长。诊断技术的进步同样是推动市场发展的重要因素，其中拥有先进医疗体系的北美和欧洲占据了相当大的市场份额。同时，亚太地区也展现出巨大的发展潜力，这主要得益于医疗投入的增加和公众意识的提升。一个值得关注的趋势是，就地检验）正日益普及，它能够实现即时评估和及时医疗干预，这对于医疗资源匮乏的地区尤其重要。

早产儿诊断检测套组市场驱动因素

早产率（指妊娠不足37週分娩）的上升已成为全球公共卫生面临的重大挑战。这一趋势促使人们迫切需要准确可靠的诊断检测套组来识别和预测早产。对改善孕产妇和新生儿健康的重视，以及医疗机构和政策制定者为降低早产率所做的努力，确保了对这些重要诊断工具的持续需求。随着人们对早产影响的认识不断提高，预计这些检测套组的市场将进一步扩大。

早产诊断检测套组市场的限制

由于医疗诊断行业受到严格监管，以确保患者安全和产品有效性，早产儿诊断检测套组市场面临严峻挑战。开发和推出新的诊断检测套组，特别是那些专注于怀孕和新生儿健康的试剂盒，需要经过大量的测试和核准流程。这些监管障碍可能会阻碍创新检测套组的及时上市，最终影响其市场供应以及医疗机构和患者的接受度。

早产诊断检测套组市场趋势

受诊断技术进步的推动，早产诊断检测套组市场正经历显着的发展趋势。创新技术不断涌现，创造出更精准可靠的检测方案，使医疗专业人员能够更精确地预测早产风险。这一市场发展趋势涵盖了多种生物标记、基因检测、蛋白质组学以及其他前沿调查方法的整合，这些方法共同提高了诊断测试的敏感度和特异性。因此，人们越来越关注个人化孕产妇照护和早期疗育策略，并将这些检测套组视为改善怀孕结果和降低早产率的关键工具。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 专利分析

全球早产诊断检测套组市场规模（按检测类型和复合年增长率划分）（2026-2033 年）

• 胎儿纤维蛋白原 (fFN)检测套组
• 胎盘α-微球蛋白-1 (PAMG-1)检测套组
• 类胰岛素生长因子结合蛋白质-1 (IGFBP-1)检测套组

全球早产诊断检测套组市场规模（按检体类型和复合年增长率划分）（2026-2033 年）

• 血液样本
• 尿液样本
• 阴道分泌物样本

全球早产诊断检测套组市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊断检查室
• 专科诊所

全球早产诊断检测套组市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Roche Diagnostics（Switzerland）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• PerkinElmer（USA）
• bioMerieux（France）
• Hologic, Inc.（USA）
• Qiagen（Netherlands）
• Danaher Corporation（USA）
• Cepheid（USA）
• Illumina, Inc.（USA）
• Sysmex Corporation（Japan）
• Agilent Technologies（USA）
• Bio-Rad Laboratories（USA）
• GenMark Diagnostics（USA）
• Luminex Corporation（USA）
• Randox Laboratories（UK）
• NanoString Technologies（USA）
• Myriad Genetics（USA）

结论与建议

Preterm Birth Diagnostic Test Kits Market size was valued at USD 163.77 Million in 2024 and is poised to grow from USD 176.21 Million in 2025 to USD 316.62 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The market for Preterm Birth Diagnostic Test Kits is experiencing significant growth, propelled by the increasing incidence of preterm births and the urgent need for early detection methods. These kits utilize biomarker analysis and clinical indicators for efficient risk assessment, backed by heightened awareness among healthcare professionals and expectant mothers. Advancements in diagnostic technology further drive this market, with North America and Europe commanding substantial shares due to their advanced healthcare systems. Meanwhile, the Asia-Pacific region showcases promising potential, spurred by rising healthcare investments and awareness levels. A notable trend is the shift toward point-of-care testing, which allows for immediate assessments and timely healthcare interventions, particularly beneficial in areas with limited access to sophisticated medical facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Preterm Birth Diagnostic Test Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Preterm Birth Diagnostic Test Kits Market Segments Analysis

Global Preterm Birth Diagnostic Test Kits Market is segmented by Test Type, Sample Type, End User and region. Based on Test Type, the market is segmented into Fetal Fibronectin (fFN) Test Kits, Placental Alpha Microglobulin-1 (PAMG-1) Test Kits and Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits. Based on Sample Type, the market is segmented into Blood Sample, Urine Sample and Vaginal Discharge Sample. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Preterm Birth Diagnostic Test Kits Market

The rising prevalence of preterm births, characterized by delivery before 37 weeks of pregnancy, presents a critical public health challenge worldwide. This growing trend fuels the need for precise and dependable diagnostic test kits aimed at identifying and forecasting preterm labor. The focus on enhancing maternal and neonatal health outcomes, along with the efforts of healthcare providers and policymakers to mitigate preterm birth rates, ensures a sustained demand for these essential diagnostic tools. As awareness of the implications of preterm birth continues to grow, the market for these test kits is expected to expand further.

Restraints in the Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kits market faces significant challenges due to the stringent regulations governing the medical diagnostic industry, which are in place to safeguard patient safety and ensure product effectiveness. The process of developing and bringing new diagnostic test kits to market, particularly those focused on pregnancy and neonatal health, involves extensive testing and approval requirements. These regulatory obstacles can hinder the timely launch of innovative test kits, ultimately affecting their market availability and the rate at which they are adopted by healthcare providers and patients alike.

Market Trends of the Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kits market is experiencing a significant trend driven by advancements in diagnostic technologies. Innovations are leading to the creation of more accurate and reliable testing options that empower healthcare professionals to predict preterm birth risk with enhanced precision. This market evolution encompasses the integration of diverse biomarkers, genetic testing, and proteomics, alongside other cutting-edge methodologies, which collectively improve the sensitivity and specificity of the diagnostic tests. As a result, the focus on personalized maternal care and early intervention strategies is intensifying, positioning these test kits as crucial tools in improving pregnancy outcomes and reducing preterm birth rates.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Preterm Birth Diagnostic Test Kits Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Fetal Fibronectin (fFN) Test Kits
• Placental Alpha Microglobulin-1 (PAMG-1) Test Kits
• Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits

Global Preterm Birth Diagnostic Test Kits Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood Sample
• Urine Sample
• Vaginal Discharge Sample

Global Preterm Birth Diagnostic Test Kits Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Clinics

Global Preterm Birth Diagnostic Test Kits Market Size & CAGR (2026-2033)

• North America (Test Type, Sample Type, End User)
  • US
  • Canada
• Europe (Test Type, Sample Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Sample Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Sample Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Sample Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations